Simulated digest of a glucosamine-based equine nutraceutical modifies effect of IL-1 in a cartilage explant model of inflammation.
Pearson
W
W
CanTox Health Sciences International, Mississauga, ON, Canada. wpearson@cantox.com
Lindinger
M I
MI
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D002358:Cartilage, Articular / Q000187:drug effects* / Q000378:metabolism; D004359:Drug Therapy, Combination; D005944:Glucosamine / Q000008:administration & dosage / Q000627:therapeutic use*; D006734:Horse Diseases / Q000188:drug therapy* / Q000378:metabolism; D006736:Horses; D007213:Indomethacin / Q000008:administration & dosage / Q000627:therapeutic use*; D007249:Inflammation / Q000188:drug therapy / Q000378:metabolism / Q000662:veterinary*; D007375:Interleukin-1 / Q000378:metabolism*; D008954:Models, Biological; D013552:Swine
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007375:Interleukin-1; D005944:Glucosamine; D007213:Indomethacin